GleamWall
中文EN

VXRT Vaxart, Inc.

Biological Products, (No Diagnostic Substances) · OTC · SEC CIK 72444 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY22.3%
TTM net income YoY157.3%
TTM EPS YoY—
Revenue 3-yr CAGR252.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin16.6%
Net margin16.0%
FCF margin17.6%
EBITDA margin19.3%

Returns

ROE62.4%
ROA16.3%
ROIC (approx.)143.3%
Asset turnover1.02x

Leverage & solvency

Liabilities / assets55.3%
Debt / equity0.00x
Current ratio1.71x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.13x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue0.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$237.26M$28.70M
R&D expense$201.58M$74.21M
SG&A expense$17.61M$20.78M
Operating income$18.07M-$66.29M
Pretax income$16.80M-$66.69M
Income tax$476,000$260,000
Net income$16.33M-$66.95M
EBITDA$26.65M-$57.44M
EPS (basic)0.07-0.33
EPS (diluted)0.07-0.33
Weighted avg. shares (diluted)230.35M202.14M
Balance sheet
Cash & equivalents$53.81M$25.23M
Short-term investments$9.99M$26.49M
Receivables$14.56M$5.76M
Current assets$136.12M$68.26M
PP&E, net$5.43M$8.71M
Goodwill$4.51M$4.51M
Intangibles$2.83M$3.56M
Total assets$186.08M$166.39M
Current liabilities$86.75M$90.88M
Total liabilities$98.28M$107.46M
Shareholders' equity$87.80M$58.92M
Shares outstanding240.49M227.77M
Cash flow statement
Operating cash flow$7.71M-$44.76M
Capital expenditure$145,000$554,000
Free cash flow$7.57M-$45.32M
Investing cash flow$16.63M-$21.32M
Financing cash flow$4.24M$56.56M
Depreciation & amortization$8.58M$8.85M
Stock-based compensation$8.31M$11.50M

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.